{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:13:19Z","timestamp":1773285199009,"version":"3.50.1"},"reference-count":22,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.3892\/etm.2014.1475","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T12:50:13Z","timestamp":1388753413000},"page":"649-653","source":"Crossref","is-referenced-by-count":10,"title":["Effects of the antihypertensive drug benidipine on osteoblast function in vitro"],"prefix":"10.3892","volume":"7","author":[{"given":"BAIXIANG","family":"WANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MING","family":"BI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHEN","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LEI","family":"WU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JINGYUN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,1,3]]},"reference":[{"key":"key20180108124807_b1-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ocl.2013.01.005","article-title":"Osteoporosis diagnosis and medical treatment","volume":"44","author":"Warriner","year":"2013","journal-title":"Orthop Clin North Am"},{"key":"key20180108124807_b2-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40265-012-0003-1","article-title":"The pathogenesis, treatment and prevention of osteoporosis in men","volume":"73","author":"Mosekilde","year":"2013","journal-title":"Drugs"},{"key":"key20180108124807_b3-etm-07-03-0649","first-page":"563","article-title":"Periodontal disease in women in post-menopause and its relationship with osteoporosis","volume":"34","author":"de Bertulucci","year":"2012","journal-title":"Rev Bras Ginecol Obstet"},{"key":"key20180108124807_b4-etm-07-03-0649","first-page":"34","article-title":"Oral cavity features in patients suffering from osteogenesis imperfecta","volume":"193","author":"Alania","year":"2011","journal-title":"Georgian Med News"},{"key":"key20180108124807_b5-etm-07-03-0649","first-page":"w13624","article-title":"The future of osteoporosis treatment - a research update","volume":"142","author":"Lippuner","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"key20180108124807_b6-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11914-011-0078-8","article-title":"Bone development: overview of bone cells and signaling","volume":"9","author":"Teti","year":"2011","journal-title":"Curr Osteoporos Rep"},{"key":"key20180108124807_b7-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/978-1-4020-6191-2_21","article-title":"Calcium signalling and calcium transport in bone disease","volume":"45","author":"Blair","year":"2007","journal-title":"Subcell Biochem"},{"key":"key20180108124807_b8-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1254\/jphs.DTJ05001X","article-title":"Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker","volume":"100","author":"Yao","year":"2006","journal-title":"J Pharmacol Sci"},{"key":"key20180108124807_b9-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s002239900478","article-title":"Effect of benidipine hydrochloride, a dihydropyridine-type calcium antagonist, on the function of mouse osteoblastic cells","volume":"62","author":"Kosaka","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"key20180108124807_b10-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell"},{"key":"key20180108124807_b11-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","article-title":"The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation","volume":"108","author":"Nakashima","year":"2002","journal-title":"Cell"},{"key":"key20180108124807_b12-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(00)80258-5","article-title":"Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts","volume":"89","author":"Komori","year":"1997","journal-title":"Cell"},{"key":"key20180108124807_b13-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1101\/gad.13.8.1025","article-title":"A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development","volume":"13","author":"Ducy","year":"1999","journal-title":"Genes Dev"},{"key":"key20180108124807_b14-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/jcp.24278","article-title":"Osteocalcin: skeletal and extra-skeletal effects","volume":"228","author":"Neve","year":"2013","journal-title":"J Cell Physiol"},{"key":"key20180108124807_b15-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/ng1916","article-title":"BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing","volume":"38","author":"Tsuji","year":"2006","journal-title":"Nat Genet"},{"key":"key20180108124807_b16-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/00220345910700030401","article-title":"Alkaline phosphatase induces the deposition of calcified layers in relation to dentin: an in vitro study to mimic the formation of afibrillar acellular cementum","volume":"70","author":"Beertsen","year":"1991","journal-title":"J Dent Res"},{"key":"key20180108124807_b17-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12011-012-9486-6","article-title":"The dual-effects of LaCl3 on the proliferation, osteogenic differentiation, and mineralization of MC3T3-E1 cells","volume":"150","author":"Liu","year":"2012","journal-title":"Biol Trace Elem Res"},{"key":"key20180108124807_b18-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12011-012-9423-8","article-title":"The effects of Ce on the proliferation, osteogenic differentiation and mineralization function of MC3T3-E1 cells in vitro","volume":"149","author":"Liu","year":"2012","journal-title":"Biol Trace Elem Res"},{"key":"key20180108124807_b19-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00223-001-1010-5","article-title":"A potent 1,4-dihydropyridine L-type calcium channel blocker, benidipine, promotes osteoblast differentiation","volume":"70","author":"Nishiya","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"key20180108124807_b20-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1248\/bpb.24.628","article-title":"Effects of various antihypertensive drugs on the function of osteoblast","volume":"24","author":"Nishiya","year":"2001","journal-title":"Biol Pharm Bull"},{"key":"key20180108124807_b21-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12170-012-0248-y","article-title":"Links between hypertension and osteoporosis: benidipine ameliorates osteoporosis in ovariectomized hypertensive rats through promotion of osteoblast proliferation and inhibition of osteoclast differentiation","volume":"6","author":"Shimizu","year":"2012","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"key20180108124807_b22-etm-07-03-0649","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2710.2005.00682.x","article-title":"Pharmacokinetics and pharmacodynamics of benidipine using a slow receptor-binding model","volume":"30","author":"Yun","year":"2005","journal-title":"J Clin Pharm Ther"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2014.1475\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T22:06:59Z","timestamp":1515449219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2014.1475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,3]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,1,3]]},"published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.3892\/etm.2014.1475"],"URL":"https:\/\/doi.org\/10.3892\/etm.2014.1475","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,3]]}}}